Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.53 USD | -5.04% | -3.34% | +50.30% |
Mar. 18 | Sector Update: Health Care Stocks Edge Up Late Monday Afternoon | MT |
Mar. 18 | Sector Update: Health Care Stocks Rise Monday Afternoon | MT |
Financials (USD)
Sales 2024 * | 17.85M | Sales 2025 * | 64.39M | Capitalization | 206M |
---|---|---|---|---|---|
Net income 2024 * | -52M | Net income 2025 * | -28M | EV / Sales 2024 * | 11.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
-3.92
x | P/E ratio 2025 * |
-7.87
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.9% |
Latest transcript on Abeona Therapeutics Inc.
1 day | -5.04% | ||
1 week | -3.34% | ||
Current month | +3.86% | ||
1 month | +7.73% | ||
3 months | +51.51% | ||
6 months | +74.31% | ||
Current year | +50.30% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 7.53 | -5.04% | 245,982 |
24-04-17 | 7.93 | +2.19% | 729,644 |
24-04-16 | 7.76 | +1.57% | 218,567 |
24-04-15 | 7.64 | +1.19% | 113,688 |
24-04-12 | 7.55 | -3.08% | 188,039 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.30% | 206M | |
-1.82% | 41.35B | |
+42.44% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- ABEO Stock